Lazard Asset Management LLC Codexis, Inc. Transaction History

Lazard Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.06 - $12.86 $509 - $1,080	-84 Reduced 1.32%	6,273 $38,000
Q2 2022 Aug 09, 2022	BUY	$8.35 - $21.89 $53,080 - $139,154	6,357 New	6,357 $66,000
Q4 2020 Feb 11, 2021	SELL	$11.7 - $23.41 $50,766 - $101,575	-4,339 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$11.21 - $13.82 $8,362 - $10,309	-746 Reduced 14.67%	4,339 $50,000
Q2 2020 Aug 13, 2020	BUY	$9.8 - $12.77 $12,563 - $16,371	1,282 Added 33.71%	5,085 $57,000
Q1 2020 May 14, 2020	BUY	$8.78 - $18.6 $33,390 - $70,735	3,803 New	3,803 $42,000
Q3 2018 Nov 13, 2018	SELL	$13.35 - $19.1 $1.26 Million - $1.8 Million	-94,366 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$10.35 - $16.45 $976,688 - $1.55 Million	94,366 New	94,366 $1.36 Million

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.